Who We Are

  NetNoggin®, a subsidiary of Conger Consulting, LLC, is a premier market research agency that specializes in pharmaceutical marketing. NetNoggin® has expertise in market research; commercial, market, and clinical development; and communications to provide reliable research, presentations, and workshops. NetNoggin® utilizes netnography to analyze and provide context to Big Data. Our proprietary process derives strategic consulting insights from Big Data to inform Foundational Marketing Tools (FMTs), strategies, and tactics. 

"The NetNoggin® team was able to cut through the social clutter to garner key insights on where to play and how to win by reaching the right patients through the right digital channels. A true partnership in an attempt to improve patients’ lives. Professional. Insightful. Purposeful.”

"NetNoggin's report has richer, deeper insights that include potential leverage points versus any of the other patient journey research we did with previous companies.”

"Working with NetNoggin® was such a pleasure. They partnered with us every step of the way in providing a comprehensive approach, extensive research, incredibly well-prepared analysis, and a thought-provoking workshop that led our team to some great insights that have definitely helped inform our approach."  

How Our Research Fits into Your Development Cycle

  NetNoggin® can support your product development throughout its entire life cycle. We provide multiple solutions to every phase of your product’s journey to give your product the best opportunity in the market. 


NetNoggin® Offerings

 We offer syndicated research and custom research giving you insights from clinical literature, Big Data, and patient/caregiver voice.

NetNoggin® Difference

 We understand the application of netnography and how to bridge the gap between the disease, the market, and the patient/caregiver voice. 

NetNoggin® Value

  We bring context to Big Data and transform it into actionable insights for your product development and foundational marketing tools. 


Subscribe to get notified of our latest disease-focused NetNog: #genesis® research.



Contact us